Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 535

2.
4.

Antiparkinsonian potential of interaction of LEK-8829 with bromocriptine.

Zivin M, Sprah L, Sket D.

Eur J Pharmacol. 1998 May 22;349(2-3):151-7.

PMID:
9671092
5.

Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841.

Krisch I, Bole-Vunduk B, Pepelnak M, Lavric B, Ocvirk A, Budihna MV, Sket D.

J Pharmacol Exp Ther. 1994 Oct;271(1):343-52.

PMID:
7965734
7.
9.
10.

Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.

Robertson GS, Robertson HA.

Brain Res. 1986 Oct 8;384(2):387-90.

PMID:
2946360
12.

A within-subjects microdialysis/behavioural study of the role of striatal acetylcholine in D1-dependent turning.

Acquas E, Fenu S, Loddo P, Di Chiara G.

Behav Brain Res. 1999 Sep;103(2):219-28.

PMID:
10513590
14.
15.

Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites.

Herrera-Marschitz M, Ungerstedt U.

Eur J Pharmacol. 1984 Feb 17;98(2):165-76.

PMID:
6143675
17.

The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.

Wirtshafter D, Osborn CV.

Eur J Pharmacol. 2005 Dec 28;528(1-3):88-94. Epub 2005 Dec 1.

PMID:
16324697
18.
20.

Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.

Schwarcz R, Fuxe K, Agnati LF, Hökfelt T, Coyle JT.

Brain Res. 1979 Jul 20;170(3):485-95.

PMID:
37986

Supplemental Content

Support Center